Introduction {#S6}
============

Poor maternal cardiac function is associated with reduced fetal growth as reflected by reduced birth weight and preterm delivery, with reduced cardiac output and maternal cyanosis suggested as underlying mechanisms \[[@R1]\]. Importantly, cardiac disease is becoming one of the leading cause of maternal death in developed countries because of increased maternal age and extended survival of patients with congenital heart disease \[[@R2]\]. As heart rate is one of the determinants of cardiac output \[[@R3]\], it is essential to know more about the significance of ranges of maternal heart rates in pregnancy. Another developing field of interest is assessment of heart rate variability (HRV) as a biomarker for autonomic nervous system (ANS) function \[[@R4]\].

There is a paucity of literature regarding maternal heart rate (MHR) under resting conditions during pregnancy, before the onset of labour. There is also little information about the periodic effects of uterine activity on the MHR prior to the onset of labour. Reports on incidental monitoring of the MHR by scalp electrodes \[[@R5],[@R6]\] or ultrasound transducers provide little information on different MHR patterns \[[@R7],[@R8]\].

The Monica AN24™ (Monica Health Care, Nottingham, UK) uses the raw data obtained from five electrodes placed on the anterior abdominal wall of the mother. The fetal (f) ECG signal quality is significantly better during the first stage of labor in comparison to Doppler cardiotocography and the monitor can provide a continuous printout of the MHR with less MHR/FHR ambiguity when compared to the cardiotocograph \[[@R9]\]. In addition, it records electrical impulses from the uterus to illustrate contraction patterns resembling what is observed with direct recordings of intrauterine pressure \[[@R10]\].

More information on the MHR is emerging, as part of the data collected in the Safe Passage Study, where fetal heart rate patterns and fetal movements were recorded at different gestational ages \[[@R11]\]. The transabdominal recording of the fetal heart rate was feasible as early as 20-24 weeks gestation \[[@R12]\]. Here we describe several unique patterns which have appeared in this data set and demonstrate its association with uterine activity at 34 to 38 weeks gestation.

Methods {#S7}
=======

The Safe Passage Study was designed to investigate the role of prenatal alcohol exposure (PAE) in 12,000 pregnancies. Recruitment included low and high risk pregnancies, with a wide range of exposures to alcohol, nicotine, cannabis and methamphetamine. Stillbirth was one of the primary outcomes. Participants from the clinical site in South Africa were recruited at a local community health centre. All assessments were done at Tygerberg Hospital. All participants had an ultrasound examination to confirm the gestational age. Ethical approval was obtained from the Health Research Ethics Committee of Stellenbosch University (Ethics approval number: N06/10/210).

Recordings were carried out in quiet rooms between 08h00 and 16h00 on weekdays with participants lying at a 15° right or left lateral tilt. For the late gestation recordings (34-38 weeks GA), four electrodes were placed on the anterior maternal abdomen, one 5 cm above the umbilicus, one just above the pubic hairline, and the other two laterally, with one 10 cm to the right and the other 5 cm to the left of the umbilicus. The fifth electrode was placed 5 cm lateral to the electrode on the right side. Before application, the skin was lightly abraded to remove superficial dry squamous cells which could reduce electrode impedance. The skin was washed with soap and water if the participant had recently used skin ointment. After application, the electrodes were connected to the Monica AN24 monitoring device which was attached to the abdominal wall with an elastic band to prevent it from moving and to ensure a similar position across all of the studies. The recordings lasted at least 50 minutes under resting conditions. During recordings, tracings of the fetal or maternal heart rate could not be seen by the operator or participant. Fetal and maternal heart rates and a tracing reflecting uterine contraction were extracted from the raw data using the DK 2.2 software provided by Monica. For this study examples of different MHR patterns were selected from recordings in more than 5,000 participants.

Results {#S8}
=======

We observed several different MHR patterns such as decreased or increased variability, tachycardia, bradycardia, decreased or increased baseline variability, regular and irregular periodic changes and sporadic changes where the heart rate suddenly decreased or increased. No participant had cardiovascular pathology.

[Figure 1](#F1){ref-type="fig"} illustrates a MHR which varied around 70 bpm. At the beginning of the recording the MHR rapidly increased to above 100 bpm but returned quickly to the baseline. Towards the end of the recording the MHR rapidly increased to 90 bpm, then decreased but did not return to the basal rate. [Figure 2](#F2){ref-type="fig"} illustrates a case where the MHR varied from around 60 bpm to just above 70 bpm on a few occasions with no periodic changes.

As illustrated in [Figure 3](#F3){ref-type="fig"}, there were cases where the MHR fluctuated rapidly between 110 and 140 bpm making it difficult to detect a baseline. In some cases there seemed to be an association between the MHR changes and uterine activity ([Figure 4](#F4){ref-type="fig"}) while in other cases the association with uterine contractions was less clear ([Figure 5](#F5){ref-type="fig"}). In [Figure 6](#F6){ref-type="fig"} the MHR was noted to fluctuate between 65 and 135 bpm. Here the association with uterine activity was less clear but the rapid decline in MHR followed periods of greater uterine activity ([Figure 6](#F6){ref-type="fig"}). In other cases it was observed that the basal MHR fluctuated around 115 bpm but was preceded and followed by periods of a lower rate (80 bpm) where the association with uterine activity was less clear ([Figure 7](#F7){ref-type="fig"}). [Figure 8](#F8){ref-type="fig"} shows a different pattern where the initial MHR varied around 120 bpm but then declined rapidly to much lower levels when uterine activity decreased ([Figure 8](#F8){ref-type="fig"}).

Overall the success rate in abstracting the MHR from the 8 cases assessed varied from 97.7% to 99.6%.The mean MHR ranged from 60.9 to 123.3 bpm ([Table 1](#T1){ref-type="table"}). Short term variability ranged from 5.2 to 32.7 ms and the mean minute range from 43.3 to 147.0 ms.

Discussion {#S9}
==========

Baseline variability {#S10}
--------------------

Heart rate variability (HRV) is the variation in HR over time and is due to variation in rapid (beat to beat), slow (seconds to minutes), and transient, event-related, changes in HR. It is predominantly dependent on extrinsic regulation of heart rate \[[@R13]\]. Assessment of HRV as a marker of ANS function and the adaptations to different physiological and pathological conditions is now receiving more attention \[[@R4]\]. HRV may be affected by different physiological and pathological conditions such as age, gender, fatigue, emotions, drugs, smoking, alcohol consumption, myocardial infection, arterial hypertension, central nervous system disorders and renal failure. In addition, mood and anxiety disorders are associated with abnormal ANS function and cause a reduction in HRV \[[@R14]\].

Rouleau *et al.* \[[@R15]\] examined whether decreased high-frequency (HF) variability mediated the association between depressed mood and gestational hypertension in 287 pregnant women. They found that depressive symptoms were associated with less HF HRV and that there was an indirect effect of depressed mood on gestational hypertension HF HRV. They concluded that cardiac vagal control was a possible pathway through which prenatal depressed mood was associated with gestational hypertension.

Murphy *et al.* \[[@R16]\] studied the effect of pregnancy on postpartum parameters of the electrocardiogram, and determined how a history of pre-eclampsia affected these parameters. Participants consisted of non-pregnant controls, normotensive parous controls and women with a recent history of pre-eclampsia. The reductions in HRV, induced by uncomplicated pregnancy, returned to non-pregnant levels 6--8 months after delivery, but in pre-eclamptic postpartum women the HRV remained reduced compared to the controls.

In a case control study, Braeken *et al.* \[[@R17]\] examined whether anxiety-related conditions, such as reduced autonomic cardiac control, reflected by reduced HRV, could persist after correction of the disorder. They found that pregnant women with previous but not current anxiety and their children had lower HRV. A model of autonomic imbalance may provide a unifying framework within which to investigate the impact of risk factors, including psychosocial factors and work stress, on cardiovascular disease \[[@R18]\].

Basal heart rate {#S11}
----------------

### Tachycardia: {#S12}

The maternal heart rate begins to increases during the first few weeks of pregnancy and peaks in the late second to early third trimester \[[@R19]\]. After 32 weeks, the maintenance of cardiac output becomes more dependent on heart rate due to the fall in stroke volume. During pregnancy, the mean maternal heart rate usually increases by an average of 10 to 20 beats per minute \[[@R19]\]. Tachycardia is therefore defined as a rate of at least 100 beats per minute under resting conditions \[[@R20]\].

Few articles in the literature address maternal tachycardia but it is referred to when cardiac disease or the use of sympathomimetics are investigated. Nel examined 1431 participants of the Safe Passage Study. Tachycardia was found in 7.1% of these cases. When they were compared to controls at similar gestations without tachycardia, no unexpected medical conditions or poor perinatal outcome were detected. Interestingly, the birth weights in the tachycardia group were significantly higher and the difference could not be explained by cigarette smoking, gestational age or sex of the newborn \[[@R21]\]. However, Carson *et al.* \[[@R22]\] found a higher prevalence of tachycardia (29%) in healthy, asymptomatic patients in the third trimester of pregnancy.

### Bradycardia: {#S13}

The definition of bradycardia in pregnancy has not been standardized. Vasapollo *et al.* \[[@R23]\] compared MHRs in primigravidae with intrauterine growth restriction to normal control pregnancies and found the pulse rates were 82 bpm and 86 bpm (p=0.03) respectively. Everette *et al.* \[[@R24]\] studied 99 pregnant women between 23 and 30 weeks. They found a significant correlation between MHR and birth weight z-scores (r=0.22, p=0.03) and suggested that a reduced maternal cardiac output with a lower MHR may indicate poor cardiovascular adaptation in early pregnancy.

Periodic changes {#S14}
----------------

To determine the effect of maternal position on periodic changes of the maternal heart rate Ibrahim *et al.* \[[@R25]\] did a prospective observational study in pregnant women before elective caesarean section. Continuous transabdominal non-invasive recording of MHR, fetal heart rate patterns and uterine activity were done for one hour in 119 women. Maternal position was changed every 15 minutes from lateral, to supine, then the other lateral and then supine again. MHRs were four beats per minute slower in the left lateral position when compared to the right lateral position. Periodic maternal heart rate changes were seen in 10.9% of participants. Most of these (84.6%) were associated with uterine activity and not maternal position. They concluded that in a subgroup of pregnant women at term, uterine activity was associated with periodic changes of MHR. In low risk pregnancies there seemed to be no effect on the fetal heart rate pattern but the implications for the compromised fetus are still unsure. They postulated that displacement of blood from the uterus and choriodecidual space into the venous circulation increases the preload to the heart which then increases myocardial contractility and is associated with a short increase in MHR \[[@R3]\].

They also stated that mechanism for periodic decline of the MHR is different, as aortocaval compression during the supine position could play a role as it could lead to decreased venous return to the heart and this subsequent decrease in preload could cause deceleration of the MHR. They suspected that reduced venous return to the heart could still occur in the lateral positions as they also found a decline in the MHR in these positions. An explanation for this was that aortacaval compression probably occurs more often when the uterus contracts. When the uterus is relaxed it would mold around the great vessels, causing little compression. However, during contraction, compression could happen more readily, even on the lateral side as the firmer uterus would then simultaneously compress the inferior cava and anterior abdominal wall.

We have observed many unusual MHR patterns, but the clinical significance of these patterns is unclear. We are pursuing this issue through analyses of the recordings of more than 6,000 participants in the Safe Passage Study and linking the quantification of these patterns to reviews of the pregnancy outcomes to determine possible associations between the different maternal heart rate patterns and maternal and fetal outcome.
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![The upper part of the graph depicts a normal fetal heart rate. The middle part illustrates the maternal heart rate (MHR) which varies around 70 bpm. At the beginning of the recording the MHR rapidly increased to above 100 bpm but returned rapidly to the baseline. Towards the end of the recording the MHR rapidly increased to 90 bpm but then decreased but not to the basal rate. The lower graph gives an indication of uterine activity\
The vertical scale gives the heart rate in beats per minute and the horizontal scale time in minutes.](nihms-990898-f0001){#F1}

![The MHR varies around 60 bpm\
The vertical scale gives the heart rate in beats per minute and the horizontal scale time in minutes.](nihms-990898-f0002){#F2}

![The MHR varies around 120 bpm. No periodic changes are observed\
The vertical scale gives the heart rate in beats per minute and the horizontal scale time in minutes.](nihms-990898-f0003){#F3}

![The MHR fluctuates rapidly between 90 and 130 bpm. It is difficult to detect the baseline. There seems to be an association between the MHR changes and uterine activity\
The vertical scale gives the heart rate in beats per minute and the horizontal scale time in minutes.](nihms-990898-f0004){#F4}

![The MHR fluctuates between 90 and 130 bpm. The association with uterine contractions is less clear. The basal heart rate seems to be around 120 bpm\
The vertical scale gives the heart rate in beats per minute and the horizontal scale time in minutes.](nihms-990898-f0005){#F5}

![The MHR fluctuates between 65 and 135 bpm. Association with uterine activity is less clear but a rapid decline in MHR seems to follow periods of greater uterine activity\
The vertical scale gives the heart rate in beats per minute and the horizontal scale time in minutes.](nihms-990898-f0006){#F6}

![The basal MHR fluctuates around 115 bpm but is preceded and followed by periods of a lower. Association with uterine activity is less clear\
The vertical scale gives the heart rate in beats per minute and the horizontal scale time in minutes.](nihms-990898-f0007){#F7}

![The initial MHR varies around 120 bpm but then declines rapidly to much lower levels when uterine activity also became less\
The vertical scale gives the heart rate in beats per minute and the horizontal scale time in minutes.](nihms-990898-f0008){#F8}

###### 

Analyses of maternal heart rate by software of the system

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Participant   Success Rate\   Mean MHR^[a](#TFN2){ref-type="table-fn"}^\   STV^[b](#TFN3){ref-type="table-fn"}^ (ms)   MMR^[c](#TFN4){ref-type="table-fn"}^ (ms)
                (%)             (bpm)                                                                                    
  ------------- --------------- -------------------------------------------- ------------------------------------------- -------------------------------------------
  1             99.5            73.6                                         21.5                                        109.6

  2             98.4            60.9                                         32.7                                        147.0

  3             97.7            123.3                                        7.8                                         43.3

  4             99.6            100.5                                        16.8                                        123.1

  5             99.5            104.7                                        5.2                                         61.6

  6             99.1            96.6                                         13.7                                        101.5

  7             99.5            87.5                                         13.6                                        91.9

  8             98.3            80.3                                         27.4                                        134.1
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------

The success rate refers to the extraction of the MHR from the raw data.

MHR = Maternal heart rate

STV = short term variability

MMR = Mean minute range
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